{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:01:20Z","timestamp":1776909680466,"version":"3.51.2"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bulgarian Ministry of Education and Science","award":["BG-RRP-2.004-0006-C03"],"award-info":[{"award-number":["BG-RRP-2.004-0006-C03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: Beh\u00e7et\u2019s disease (BD) is a systemic inflammatory disorder marked by recurrent mucocutaneous and ocular manifestations, predominantly affecting populations along the historic Silk Road. Genetic susceptibility, especially involving HLA-B*51, is well established. Spondyloarthritis (SpA) shares immunogenetic and clinical overlaps with BD, notably through associations with HLA class I alleles, particularly HLA-B*27. However, extended HLA-B allele profiling in these conditions remains limited. This study aimed to investigate the extended distribution of HLA-B alleles in patients presenting with clinical features suggestive of BD or SpA and to compare their clinical and laboratory profiles. Methods: In a prospective observational study at a Bulgarian rheumatology center, 120 patients with suspected BD or SpA were enrolled between January 2023 and June 2025. Diagnoses were confirmed using International Criteria for Beh\u00e7et\u2019s Disease (ICBD) and ASAS criteria for SpA. Comprehensive clinical evaluations, laboratory assessments including HLA-B typing by Sanger sequencing, and inflammatory markers were collected and analyzed. Results: Of the cohort, 15 patients (12.5%) were diagnosed with BD and 30 (25%) with SpA. HLA-B*51 was predominantly associated with BD, while HLA-B*27 and its heterozygous combinations were prevalent in SpA patients. Suspected BD patients exhibited significantly higher levels of inflammatory markers (CRP, ESR) and characteristic clinical features such as oral\/genital ulcers and uveitis compared to non-BD patients. Suspected SpA patients showed longer disease duration, increased NSAID use and higher prevalence of enthesitis, psoriasis and peripheral arthritis compared to non-SpA patients. Conclusions: This study confirms the strong associations of HLA-B*51 with Beh\u00e7et\u2019s disease and HLA-B*27 with spondyloarthritis while revealing additional heterozygous and less common alleles that suggest a broader genetic influence. These findings highlight the genetic diversity and clinical heterogeneity of BD and SpA, supporting the use of extended HLA typing to improve the diagnosis and understanding of these diseases.<\/jats:p>","DOI":"10.3390\/life16030409","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:45:12Z","timestamp":1772531112000},"page":"409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of HLA-B Typing in Beh\u00e7et\u2019s Disease and Spondyloarthritis: Genetic and Clinical Insights"],"prefix":"10.3390","volume":"16","author":[{"given":"Elena","family":"Bischoff","sequence":"first","affiliation":[{"name":"Department of Health Care, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stoyanka","family":"Vladeva","sequence":"additional","affiliation":[{"name":"Department of Health Care, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Bischoff","sequence":"additional","affiliation":[{"name":"Rheumatology Practice Stara Zagora, 6000 Stara Zagora, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-2448","authenticated-orcid":false,"given":"Nikola","family":"Kirilov","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Traumatology, University Hospital UMBAL Dr. Georgi Stranski, Medical University of Pleven, 5803 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lavalle, S., Caruso, S., Foti, R., Gagliano, C., Cocuzza, S., La Via, L., Parisi, F.M., Calvo-Henriquez, C., and Maniaci, A. (2024). Beh\u00e7et\u2019s disease: Pathogenesis, clinical features and treatment approaches\u2014A comprehensive review. Medicina, 60.","DOI":"10.3390\/medicina60040562"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"945262","DOI":"10.1155\/2015\/945262","article-title":"Beh\u00e7et\u2019s disease: Is there geographical variation? A review far from the Silk Road","volume":"2015","author":"Leonardo","year":"2015","journal-title":"Int. J. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.21926\/obm.genet.2403261","article-title":"Clinical features, genetic landscape and management of Beh\u00e7et\u2019s syndrome: A comprehensive review","volume":"8","author":"Masiello","year":"2024","journal-title":"OBM Genet."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Leccese, P., and Alpsoy, E. (2019). Beh\u00e7et\u2019s disease: An overview of etiopathogenesis. Front Immunol., 10.","DOI":"10.3389\/fimmu.2019.01067"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110549","DOI":"10.1016\/j.clim.2025.110549","article-title":"Etiopathogenesis of Beh\u00e7et\u2019s disease: A systematic literature review","volume":"279","author":"Choukri","year":"2025","journal-title":"Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","article-title":"The immunogenetics of Beh\u00e7et\u2019s disease: A comprehensive review","volume":"64","author":"Takeuchi","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0198-8859(00)00249-4","article-title":"HLA-B51 and B15 alleles confer predisposition to Beh\u00e7et\u2019s disease in Moroccan patients","volume":"62","author":"Chakib","year":"2001","journal-title":"Hum. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/s41598-024-58254-w","article-title":"Novel genetic variants of HLA gene associated with Thai Beh\u00e7et\u2019s disease (BD) patients using next generation sequencing technology","volume":"14","author":"Sornsamdang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019\u2014Unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13317-019-0112-x","article-title":"Association of HLA-B27 and Beh\u00e7et\u2019s disease: A systematic review and meta-analysis","volume":"10","author":"Khabbazi","year":"2019","journal-title":"Autoimmun. Highlights"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter\u2019s disease, the intestinal arthropathies and Beh\u00e7et\u2019s syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.12998\/wjcc.v10.i3.992","article-title":"Occurrence of human leukocyte antigen B51-related ankylosing spondylitis in a family: Two case reports","volume":"10","author":"Lim","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_13","first-page":"112","article-title":"Coexistence of Beh\u00e7et\u2019s disease and ankylosing spondylitis","volume":"10","author":"Karahan","year":"2013","journal-title":"Eur. J. Gen. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002960000052","article-title":"The coexistence of Beh\u00e7et\u2019s disease and ankylosing spondylitis","volume":"19","author":"Borman","year":"2000","journal-title":"Rheumatol. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e12973","DOI":"10.1111\/sji.12973","article-title":"Beh\u00e7et disease (BD) and BD-like clinical phenotypes: NF-\u03baB pathway in mucosal ulcerating diseases","volume":"92","author":"Perazzio","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-018-0100-z","article-title":"Role of human leukocyte antigens (HLA) in autoimmune diseases","volume":"5","author":"Bodis","year":"2018","journal-title":"Rheumatol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1525-1578(10)60658-7","article-title":"Human leukocyte antigen gene polymorphism and the histocompatibility laboratory","volume":"3","author":"Williams","year":"2001","journal-title":"J. Mol. Diagn."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD) (2014). The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J. Eur. Acad. Dermatol. Venereol., 28, 338\u2013347.","DOI":"10.1111\/jdv.12107"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/ard.2008.096073","article-title":"ASAS\/EULAR recommendations for the management of ankylosing spondylitis: The patient version","volume":"68","author":"Kiltz","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13075-015-0585-6","article-title":"Characterization of the major histocompatibility complex locus association with Beh\u00e7et\u2019s disease in Iran","volume":"17","author":"Xavier","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.50.6.351","article-title":"Close association of HLA-B51 and B52 in Israeli patients with Beh\u00e7et\u2019s syndrome","volume":"50","author":"Arber","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2478\/rir-2021-0013","article-title":"A Darwinian view of Beh\u00e7et\u2019s disease","volume":"2","author":"Smith","year":"2021","journal-title":"Rheumatol. Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4049\/jimmunol.1801178","article-title":"KIR3DL1\/S1 allotypes contribute differentially to the development of Beh\u00e7et disease","volume":"203","author":"Petrushkin","year":"2019","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000348366","article-title":"HLA-A, B (class I) and HLA-DR, DQ (class II) antigens in Turkish patients with recurrent aphthous ulceration and Beh\u00e7et\u2019s disease","volume":"22","author":"Pekiner","year":"2013","journal-title":"Med. Princ. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0198-8859(80)90008-7","article-title":"A public antigenic determinant in the HLA-B5 cross-reacting group\u2014A basis for cross-reactivity and a possible link with Beh\u00e7et\u2019s disease","volume":"1","author":"Schwartz","year":"1980","journal-title":"Hum. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13317-013-0047-6","article-title":"New insights into HLA class I association to Beh\u00e7et\u2019s syndrome in Iranian Azari patients","volume":"4","author":"Shahneh","year":"2013","journal-title":"Autoimmun. Highlights"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clineuro.2007.01.009","article-title":"Juvenile Beh\u00e7et\u2019s disease: Highlighting neuropsychiatric manifestations and putative genetic mechanisms","volume":"109","author":"Panicker","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.56766\/ntms.1526917","article-title":"Detecting the presence of anti-HLA antibodies in autoimmune diseases","volume":"5","year":"2024","journal-title":"New Trends Med. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nagit, R.E., Pavel-Tanasa, M., Cianga, C., Rezus, E., and Cianga, P. (2025). Genetic complexity in spondyloarthritis: Contributions of HLA-B alleles beyond HLA-B*27 in Romanian patients. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157617"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","article-title":"HLA class I and II alleles in susceptibility to ankylosing spondylitis","volume":"78","author":"Reveille","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wu, X., Wu, J., Li, X., Wei, Q., Lv, Q., Zhang, P., Zheng, X., Chen, Z., Cao, S., and Tu, L. (2021). The clinical characteristics of other HLA-B types in Chinese ankylosing spondylitis patients. Front. Med., 7.","DOI":"10.3389\/fmed.2020.568790"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e009092","DOI":"10.1136\/bmjopen-2015-009092","article-title":"Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns","volume":"5","author":"Santos","year":"2015","journal-title":"BMJ Open"},{"key":"ref_35","first-page":"93","article-title":"Frequency of HLA-class I allel in patients with spondyloarthropathy","volume":"2","author":"Temurhan","year":"2019","journal-title":"J. Adv. Res. Health Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Parsaei, A., Moradi, S., Masoumi, M., Davatchi, F., Najafi, A., Kooshki, A.M., Hajighadery, A., Akhlaghi, M., Faezi, T., and Kavosi, H. (2022). Predictive value of erythrocyte sedimentation rate and C-reactive protein in Beh\u00e7et\u2019s disease activity and manifestations: A cross-sectional study. BMC Rheumatol., 6.","DOI":"10.1186\/s41927-021-00241-z"},{"key":"ref_37","first-page":"367","article-title":"Do routine laboratory parameters predict the disease activity in children with Beh\u00e7et\u2019s disease?","volume":"34","author":"Yildirim","year":"2023","journal-title":"Gazi Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kjms.2015.10.010","article-title":"The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and mean platelet volume with the presence and severity of Beh\u00e7et\u2019s syndrome","volume":"31","author":"Alan","year":"2015","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5152\/eurjrheum.2016.038","article-title":"Do clinical findings of Beh\u00e7et\u2019s disease vary by gender? A single-center experience from 329 patients","volume":"3","author":"Cansu","year":"2016","journal-title":"Eur. J. Rheumatol."},{"key":"ref_40","first-page":"471","article-title":"Beh\u00e7et\u2019s disease, hospital-based prevalence and manifestations in the Rotterdam area","volume":"73","author":"Kappen","year":"2015","journal-title":"Neth. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: A meta-analysis","volume":"18","author":"Baeten","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","article-title":"The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients","volume":"78","author":"Dougados","year":"2011","journal-title":"Jt. Bone Spine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr2.11139","article-title":"Incidence of uveitis in secukinumab-treated patients with ankylosing spondylitis: Pooled data analysis from three phase 3 studies","volume":"2","author":"Deodhar","year":"2020","journal-title":"ACR Open Rheumatol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/409\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:35:12Z","timestamp":1772534112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["life16030409"],"URL":"https:\/\/doi.org\/10.3390\/life16030409","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}